Phase I Trial of Liposomal Doxorubicin (Doxil) Based Combination Chemotherapy Regimen in AIDS-Associated Non-Hodgkin's Lymphoma

Next Previous
Trial Profile

Phase I Trial of Liposomal Doxorubicin (Doxil) Based Combination Chemotherapy Regimen in AIDS-Associated Non-Hodgkin's Lymphoma

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jun 2009

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Methotrexate; Prednisone; Vincristine
  • Indications Non-Hodgkin's lymphoma
  • Focus Adverse reactions

    • Most Recent Events

    • 12 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top